Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology

Author:

Galle Peter R.1ORCID,Kudo Masatoshi2ORCID,Llovet Josep M.345,Finn Richard S.6,Karwal Mark7,Pezet Denis8,Kim Tae‐You9,Yang Tsai‐Sheng10,Lonardi Sara11,Tomasek Jiri12,Phelip Jean‐Marc13,Touchefeu Yann14,Koh Su‐Jin15,Stirnimann Guido16,Liang Kun17,Ogburn Kenyon D.17,Wang Chunxiao17,Abada Paolo17,Widau Ryan C.17,Zhu Andrew X.1819

Affiliation:

1. Department of Internal Medicine Mainz University Medical Center Mainz Germany

2. Departments of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka Japan

3. Mount Sinai Liver Cancer Program Division of Liver Diseases Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York NY USA

4. Translational Research in Hepatic Oncology, Liver Unit IDIBAPS, Hospital Clinic, University of Barcelona Barcelona Spain

5. Institució Catalana d’Estudis Avançats (ICREA) Barcelona Spain

6. University of California Los Angeles CA USA

7. University of Iowa Hospitals and Clinics University of Iowa Health Care Iowa City IA USA

8. Estaing Hospital Aubrac, Clermont‐Ferrand France

9. Seoul National University Hospital Seoul Korea

10. Chang Gung Memorial Hospital Taoyuan China

11. Veneto Institute of Oncology IOV‐IRCCS Padua Italy

12. Masaryk Memorial Cancer InstituteMasaryk University Brno Czech Republic

13. University Hospital Saint‐Etienne North Saint Etienne France

14. CHU Hôtel‐Dieu Nantes France

15. Division of Hematology and Oncology Ulsan University HospitalUniversity of Ulsan College of Medicine Ulsan Korea

16. University Hospital Inselspital and University of Bern Bern Switzerland

17. Eli Lilly and Company Indianapolis IN USA

18. Massachusetts General Hospital Cancer Center Boston MA USA

19. Jiahui International Cancer Center Jiahui Health Shanghai China

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3